EFDID: 44737EFD: View Filing

Issuer: Cynapsus Therapeutics Inc. (0001532079) - D/A

Accession: 0001532079-12-000001 (XMLRaw Data) (EDGAREDGAR Files) (Form DForm D)

EDGAR: Issuer Information
  • CIK:
    0001532079
  • Entity Name:
    Cynapsus Therapeutics Inc.
  • Entity Type:
    Corporation
  • Jurisdiction:
    ONTARIO, CANADA
  • Year of Inc:
    Over 5 years ago
  • Address:
    828 RICHMOND STREET WEST
    TORONTO, A6 M6J 1C9
  • Persons:
    Related Persons 9
    Anthony Giovinazzo
    Executive Officer
    Andrew Williams
    Executive Officer
    Nathan Bryson
    Executive Officer
    David Hill
    Director
    Ronald Hosking
    Director
    Julia Levy
    Director
    Alan Ryley
    Director
    Rochelle Stenzler
    Director
    Alan Torrie
    Director
EDGAR: Offering Information
  • Accession Date:
    01/09/2012
  • First Sale Date:
    09/29/2011
  • Offering Amount:
    $761,610
  • Amount Sold:
    $761,610
  • Exemptions:
    Rule 506
  • Security Type(s):
    Equity, Debt
  • Sales Clarification:
    U.S. dollar amounts are based on the Bank of Canada noon rate of exchange reported on September 29, 2011, which was Cdn$1.0338=US$1.00.
EFD: Current State Notices

No State Notices found in EFD

EDGAR: Sales Compensation Recipient Information
RecipientCRDBroker DealerBD CRDStates
Summer Street Research Partners 127142 None None CO, FL, MS, NY
EDGAR: Signatures
IssuerSignatureSigner NameTitleSignatureDate
Cynapsus Therapeutics Inc./s/ Andrew WilliamsAndrew WilliamsChief Operating Officer and Chief Financial Officer2012-01-09
Related EDGAR Submissions
Type Edgar Date EFD: Accession
D/A Mar. 28, 2012 44737: 0001532079-12-000002 Cynapsus Therapeutics Inc.
Offer Amount: $939,505
Amount Sold: $939,505
D/A Jan. 09, 2012 44737: 0001532079-12-000001 Cynapsus Therapeutics Inc.
Offer Amount: $761,610
Amount Sold: $761,610
D/A Dec. 28, 2011 44737: 0001532079-11-000003 Cynapsus Therapeutics Inc.
Offer Amount: $555,358
Amount Sold: $555,358
D/A Nov. 18, 2011 44737: 0001532079-11-000002 Cynapsus Therapeutics Inc.
Offer Amount: $389,144
Amount Sold: $389,144
D Oct. 13, 2011 44737: 0001532079-11-000001 Cynapsus Therapeutics Inc.
Offer Amount: $222,368
Amount Sold: $222,368